# FDA 483 - Galbraith Laboratories Inc - November 16, 2023

Source: https://www.keypedia.com/records/483/galbraith-laboratories-inc/041a6eb6-c541-4c83-af78-47857aaa75c1

> FDA 483 for Galbraith Laboratories Inc on November 16, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Galbraith Laboratories Inc
- Inspection Date: 2023-11-16
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: Galbraith Laboratories Inc, a contract laboratory in Knoxville, IN, was inspected by the FDA from November 15-16, 2023. The inspection revealed a significant issue regarding the firm's failure to follow its own written procedures for equipment cleaning, maintenance, and laboratory housekeeping. This indicates a lack of adherence to established quality control practices.

## Related Documents

- [483 - 2022-03-02](https://www.keypedia.com/records/483/galbraith-laboratories-inc/67d2319b-7e82-4720-b800-0978b4a88632)

## Related Officers

- [Gretchen M. Laws](https://www.keypedia.com/people/gretchen-m-laws/9a3ecebd-099b-41d5-a2a7-70811a26cae1)
- [Investigator](https://www.keypedia.com/people/clinton-j-lott/ac4c7d18-13fd-4b1b-b2a1-06794c9960c7)

Company: https://www.keypedia.com/companies/galbraith-laboratories-inc/6a269a6c-2d54-487f-93d9-8939dc052c2d

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea